Cowen Inc’s Dynavax Technologies DVAX Stock Holding History

Cowen Inc’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-29,300	Closed	-$7K	–	359
2018 Q3	$7K	Buy	+29,300	New	+$396K	﹤0.01%	470

Other funds holding DVAX

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Cowen Inc's DVAX Position: Q4 2016 in Review

Cowen Inc sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 10,000 shares — an estimated $73.3K sold.

Cowen Inc first reported a position in DVAX in Q2 2013 and held it in 4 quarters. The position peaked at $105K in Q3 2016. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

Cowen Inc reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
Cowen Inc sold 10,000 Dynavax Technologies shares in Q4 2016, an estimated $73.3K.
Cowen Inc first reported a position in Dynavax Technologies in Q2 2013 and held it in 4 quarters.
Cowen Inc's Dynavax Technologies position peaked at $105K in Q3 2016.
111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on Cowen Inc's 13F filing for Q4 2016, filed 13 Feb 2017.